Targeting abasic sites in DNA by aminoalkyl-substituted carboxamidoacridizinium derivatives and acridizinium-adenine conjugates

European Journal of Organic Chemistry

Volumn , Issue 28, 2007, Pages 4721-4730

  Benner, Katja ^a   Granzhan, Anton ^a   Ihmels, Heiko ^a   Viola, Giampietro ^b  

^a UNIVERSITY OF SIEGEN   (Germany)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Abasic DNA; Acridizinium; Adenine; DNA recognition; Nitrogen heterocycles

Indexed keywords

EID: 35348916750     PISSN: 1434193X     EISSN: 10990690     Source Type: Journal    
DOI: 10.1002/ejoc.200700207     Document Type: Article

References (39)

1. J. Lhomme, J.-F. Constant, M. Demeunynck, Biopolym. Nucl. Acid Sci. 1999, 52, 65-83.
2. O. D. Schärer, Angew. Chem. 2003, 115, 3052-3082;
3. Angew. Chem. Int. Ed. 2003, 42, 2946-2974.
4. J.-F. Constant, M. Demeunynck in DNA and RNA Binders: From Small Molecules to Drugs (Eds.: M. Demeunynck, C. Bailly, W. D. Wilson), Wiley-VCH, Weinheim, 2003, pp. 247-277.
5. For other strategies see: a) J. R. Bertrand, J.-J. Vasseur, A. Gouyette, B. Rayner, J. L. Imbach, C. Paoletti, C. Malvy, J. Biol. Chem. 1989, 264, 14172-14178;
6. b) C. Malvy, H. Safraoui, E. Bloch, J. R. Bertrand, Anti-Cancer Drug Des. 1988, 2, 361-370;
7. c) M. Jourdan, J. Garcia, J. Lhomme, M.-P. Teulade-Fichou, J-P. Vigneron, J-M. Lehn, Biochemistry 1999, 38, 14205-14213;
8. d) N. Berthet, J. Michon, J. Lhomme, M.-P. Teulade-Fichou, J.-P. Vigneron, J.-M. Lehn, Chem. Eur. J. 1999, 5, 3625-3630.
9. a) N. Berthet, J.-F. Constant, M. Demeunynck, P. Michon, J. Lhomme, J. Med. Chem. 1997, 40, 3346-3352;
10. b) P. Belmont, M. Jordan, M. Demeunynck, J-F. Constant, J. Garcia, J. Lhomme, J. Med. Chem. 1999, 42, 5153-5159.
11. a) J-F. Constant, T. R. O'Connor, J. Lhomme, J. Laval, Nucleic Acids Res. 1988, 16, 2691-2703;
12. b) A. Fkyerat, M. Demeunynck, J.-F. Constant, P. Michon, J. Lhomme, J. Am. Chem. Soc. 1993, 115, 9952-9959.
13. A. Martelli, M. Jourdan, J.-F. Constant, M. Demeunynck, P. Dumy, Bioorg. Med. Chem. Lett. 2006, 16, 154-157.
14. H. Ihmels, K. Faulhaber, D. Vedaldi, F. Dall'Acqua, G. Viola, Photochem. Photobiol. 2005, 81, 1107-1115.
15. C. Bohne, K. Faulhaber, B. Giese, A. Hafner, A. Hofmann, H. Ihmels, A.-K. Köhler, S. Perä, F. Schneider, M. A. L. Sheepwash, J. Am. Chem. Soc. 2005, 127, 76-85.
16. C. K. Bradsher, J. C. Parham, J. Heterocycl. Chem. 1964, 1, 30-33.
17. M. Bodanszky, A. Bodanszky, The Practice of Peptide Synthesis 2nd Ed.; Springer, New York, 1994.
18. N.J. Leonard, K. Ito, J. Am. Chem. Soc. 1973, 95, 4010-4016;
19. b) M. Hisatome, N. Maruyama, K. Ikeda, T. Furutera, T. Ishikawa, K. Yamakawa, Chem. Pharm. Bull. 1996, 44, 1801-1811.
20. a) A. W. McConnaughie, T. C. Jenkins, J. Med. Chem. 1995, 38, 3488-3501;
21. b) M. Aslanoglu, Anal. Sci. 2006, 22, 439-443.
22. J. D. McGhee, P. H. von Hippel, J. Mol. Biol. 1974, 86, 469-489.
23. H. Ihmels, K. Faulhaber, C. Sturm, G. Bringmann, K. Messer, N. Gabellini, D. Vedaldi, G. Viola, Photochem. Photobiol. 2001, 74, 505-511.
24. In this work, the DNA concentration is expreesed in base pair (bp) units in the case of polynucleotides and as concentration of oligonucleotide duplexes in the case of deoxyribooligonucleo tides.
25. B. Norden, T. Kurucsev, J. Mol. Recognit. 1994, 7, 141-156.
26. a) G. Cohen, H. Eisenberg, Biopolymers 1969, 8, 45-55;
27. b) D. Suh, J. B. Chaires, Bioorg. Med. Chem. 1995, 3, 723-728.
28. See e.g a) C. Pena, I. Alfonso, B. Tooth, N.H. Voelcker, V. Gotor, J. Org. Chem. 2007, 72, 1924-1930;
29. b) S. Dallavalle, G. Giannini, D. Alloatti, A. Casati, E. Marastoni, L. Musso, L. Merlini, G. Morini, S. Penco, C. Pisano, S. Tinelli, M. De Cesare, G. L. Beretta, F. Zunino, J. Med. Chem. 2006, 49, 5177-5186;
30. c) S. Blanchard, I. Rodriguez, C. Tardy, B. Baldeyrou, C. Bailly, P. Colson, C. Houssier, S. Leonce, L. Kraus-Berthier, B. Pfeiffer, P. Renard, A. Pierre, P. Caubere, G. Guillaumet, J. Med. Chem. 2004, 47, 978-987;
31. d) L. Wang, H. L. Price, J. Juusola, M. Kline, O. Phanstiel II, J. Med. Chem. 2001, 44, 3682-3691;
32. e) J. Sartorius, H.-J Schneider, J. Chem. Soc. Perkin Trans. 2 1997, 2319-2327;
33. f) J. B. Le Pecq, M. Le Bret, J. Barbet, B. Roques, Proc. Natl. Acad. Sci USA. 1975, 72, 2915-2919.
34. W. A. Denny in DNA and RNA Binders: From Small Molecules to Drugs (Eds.: M. Demeunynck, C. Bailly, W. D. Wilson). Wiley-VCH, Weinheim, 2003, pp. 482-502.
35. M. Hannon, A. Rodger, N. H. Mann, (Univ. Warwick); WO 2005/033119, 2005.
36. a) N. J. Leonard, K. Ito, J. Am. Chem. Soc. 1973, 95, 4010-4016;
37. b) M. Hisatome, N. Maruyama, K. Ikeda, T. Furutera, T. Ishikawa, K. Yamakawa, Chem. Pharm. Bull. 1996, 44, 1801-1811.
38. D. E. Graves in DNA Topoisomerase Protocols: Enzymology and Drugs (Eds.: N. Osheroff, M. A. Bjornsti), Humana Press, Totowa, NJ, 2001, pp. 161-169.
39. P. C. Dedon in Current Protocols in Nucleic Acid Chemistry (Eds.: S. L. Beaucage, D. E. Bergstrom, G. D. Glick, R. A. Jones), John Wiley & Sons, New York, 2000.